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riving and Implantable
ardioverter-Defibrillators
Clearer View*
lair P. Grubb, MD, FACC
oledo, Ohio
he development of the implantable cardioverter-
efibrillator (ICD) in the early 1980s represented a mile-
tone in cardiovascular medicine. For the first time, lethal
entricular arrhythmias that occurred in a clinical setting
ould be quickly and effectively recognized and terminated
y means of a surgically implanted device. Death rates
ttributable to ventricular arrhythmias decreased markedly
n patients who received ICDs (originally sudden death
urvivors) and created a new population of patients in whom
udden death was now, for all intents and purposes, a
hronic disease. These early devices were primitive by
oday’s standards; they often took up to 15 s or more to
ecognize, charge, and defibrillate an episode of ventricular
brillation and lacked back-up pacing capacity. Thus, it was
ot uncommon for a patient to experience a syncopal or
ear-syncopal episode associated with an ICD discharge.
See page 2233
his created a dilemma for physicians caring for these
atients in respect to operating a motor vehicle, for unlike
harmacotherapy (which was theoretically supposed to pre-
ent episodes of ventricular fibrillation), the ICD could only
rescue” the patient once an episode had already occurred
1). Syncope, near syncope, or even disorientation after an
CD discharge could be disastrous while driving. It there-
ore seemed prudent to restrict the ICD patient’s ability to
rive to avoid injury to themselves or others.
Over the last 2 decades, ICD technology has dramatically
mproved. Transvenous lead placement, programmability,
iphasic wave forms, back-up and antitachycardic pacing,
uperior arrhythmias recognition, and charge times have
arkedly enhanced the ease of implantation as well as the
fficiency of these remarkable devices. At the same time, the
se of ICDs has expanded from sudden death survivors to
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From the Electrophysiology Program, Health Science Campus, University of
oledo, Toledo, Ohio.rophylactic implantation in patients who are at an in-
reased risk of sudden death, significantly expanding the
opulation of individuals with ICDs. Therefore, the issue of
riving with an ICD has become even more important.
Initial recommendations suggested that an individual
ho received an ICD as secondary prevention after an
pisode of sudden death or ventricular tachycardia (or
ndividuals who had received an appropriate ICD discharge
or ventricular tachycardia/ventricular fibrillation) wait 6
onths before resuming driving (1,2). This recommenda-
ion was based on the fact that the risk for another event is
descending experimental curve, with the greatest chance
or another arrhythmia in the period immediately after an
vent. After 3 months the curve flattens significantly, and at 6
onths it is flat. More recently, an updated set of guidelines
as issued regarding driving in patients with ICDs implanted
or primary prevention. In these individuals it was recom-
ended that driving be restricted only as long as required
or the implantation wound to heal (usually about 1 week) (2).
Most of these recommendations, however, were ham-
ered by a lack of good data regarding the actual risk of an
CD discharge during driving. In addition, many patients
ailed to comply with advice regarding restriction of driving.
n this issue of the Journal, Albert et al. (3) provide a
uch-needed addition to our understanding of the relation-
hip between driving and ICD discharges. Using data from
he TOVA (Triggers of Ventricular Arrhythmias) study,
hey analyzed data on driving habits and ICD discharges in
,188 patients. Of these, 80% reported driving their car at
east once per week (as did 75% within 6 months after
mplantation); over a median follow-up period of 562 days
here were 193 ICD shocks for ventricular tachycardia/
entricular fibrillation based on data from driving in relation
o ICD shock. This showed that an ICD shock for
entricular tachycardia or ventricular fibrillation within
hour of driving was around 1 episode per 25,116 person-
ours spent driving. Interestingly, among 7 patients who
eceived an ICD shock for ventricular tachycardia or ven-
ricular fibrillation during driving, only 1 resulted in a motor
ehicle accident.
This is certainly reassuring news for both patients with
CDs and the physicians who care for them. In most areas
f the U.S., the inability to drive places significant limita-
ions on an individual, greatly reducing their employment,
ducational, and recreational opportunities.
The investigators noted several limitations to the study.
he first was that this was an observational study that could
ot prove causality. More importantly, the assessment of
riving was by self-reporting and was not obtained anony-
ously. Patients are less likely to report events when they
hink that their driving privileges may be limited, thus some
egree of under-reporting may have occurred (1). In addi-
ion, the patients who resumed driving seemed healthier
han many patients who receive ICDs.
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Editorial Comment December 4, 2007:2241–2Despite these limitations, the work by Alpert et al. (3)
rovides important new insights in regard to driving by
atients with ICDs. Particularly fascinating is the obser-
ation that events were more likely to occur after rather
han during driving. The reasons for this association are
nclear. The investigators speculate that exposure to
articulate matter and possibly disturbances in autonomic
ervous system regulation may play a role in this observation.
How should this new information be used? The recent
pdated guidelines should continue to be followed (as
hould all state and federal regulations) as we continue to
ollect further information on driving by patients with
CDs. The report by Albert et al. (3) is a welcome
eassurance that driving can safely be resumed by many
atients with ICDs, adding increased quality of life to the
ncreased quantity of life these remarkable devices now
rovide.eprint requests and correspondence: Dr. Blair P. Grubb,
ardiovascular Medicine, Health Science Campus, University of
oledo, Mail Stop 1118, 3000 Arlington Avenue, Toledo, Ohio
3614. E-mail: blair.grubb@utoledo.edu.
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